These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16959499)

  • 1. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
    Colloby SJ; Pakrasi S; Firbank MJ; Perry EK; Piggott MA; Owens J; Wyper DJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Neuroimage; 2006 Nov; 33(2):423-9. PubMed ID: 16959499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
    Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
    Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Parkinson-dementia" diseases: a comparison by double tracer SPECT studies.
    Rossi C; Volterrani D; Nicoletti V; Manca G; Frosini D; Kiferle L; Unti E; De Feo P; Bonuccelli U; Ceravolo R
    Parkinsonism Relat Disord; 2009 Dec; 15(10):762-6. PubMed ID: 19553153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations.
    O'Brien JT; Colloby SJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED
    Neuroimage; 2008 Apr; 40(3):1056-63. PubMed ID: 18295510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW; Yoon JK; An YS; Lee PH
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia.
    Kemp PM; Hoffmann SA; Holmes C; Bolt L; Ward T; Holmes RB; Fleming JS
    Nucl Med Commun; 2005 Dec; 26(12):1099-106. PubMed ID: 16264357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies.
    Firbank MJ; Burn DJ; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):776-82. PubMed ID: 16035122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Clinical and Neuroimaging Characteristics in Early Stage Parkinson's Disease with Dementia and Dementia with Lewy Bodies.
    Takemoto M; Sato K; Hatanaka N; Yamashita T; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016; 52(1):205-11. PubMed ID: 27060948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow in Parkinson's disease with and without dementia.
    Firbank MJ; Colloby SJ; Burn DJ; McKeith IG; O'Brien JT
    Neuroimage; 2003 Oct; 20(2):1309-19. PubMed ID: 14568499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
    Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.